Nine of the 10 mice inoculated with AAV-FGF19 displayed benign hepatic tumors (hepatocellular adenoma; 6 mice), malignant hepatic tumors (hepatocellular carcinoma; 7 mice) or both (4 mice). This evidence concerns the gene FGF19 and hepatocellular carcinoma.